News
-
-
-
COMMUNIQUÉ DE PRESSE
AmplifyBio Partners with Industry Leader in Lipid Nanoparticles (LNPs) to Expand Drug Delivery Capabilities
AmplifyBio partners with Stephen Burgess, Ph.D., bringing expertise in LNP formulations for efficient mRNA delivery. Collaboration enhances lipid-based technologies for mRNA therapeutics -
-
-
COMMUNIQUÉ DE PRESSE
AmplifyBio and RNAV8 Bio Announce Strategic Partnership to Support mRNA Therapeutic Developers from Sequence Design to GMP Manufacture
AmplifyBio and RNAV8 Bio partner to offer one-stop shop for mRNA therapeutics development, integrating design, optimization, and manufacturing capabilities -
COMMUNIQUÉ DE PRESSE
AmplifyBio CEO J. Kelly Ganjei Discusses Solutions for Reducing Costs and Risk in Advanced Therapy Manufacturing During Fireside Chat at Advanced Therapies Week
J. Kelly Ganjei, CEO of AmplifyBio, shared insights at Advanced Therapies Week on the evolution of manufacturing strategies and fundraising in cell and gene therapy development. The fireside chat panel discussed early commercialization, tech transfer, and AmplifyBio's hybrid outsourcing model -
COMMUNIQUÉ DE PRESSE
AmplifyBio Celebrates Grand Opening of Manufacturing Enablement Center in New Albany, Ohio
AmplifyBio celebrates successful grand opening of AMEC, showcasing manufacturing suites and operating models for advanced therapies. Executives and key speakers highlight the milestone event's significance -
-
